Cargando…

Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness

INTRODUCTION: Targeting angiogenesis in metastatic colorectal cancer (mCRC) using bevacizumab is a standard of care. The addition of this targeted biological agent to first-line infusional fluoropyrimidine-based chemotherapy was associated with superior overall survival (OS) in several randomized an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chibani, Hind, El Bairi, Khalid, Al Jarroudi, Ouissam, Afqir, Said
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052347/ https://www.ncbi.nlm.nih.gov/pubmed/35506031 http://dx.doi.org/10.5114/wo.2022.114678

Ejemplares similares

Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their Career
por: El Bairi, Khalid, et al.
Publicado: (2021)

Ovarian cancer in Morocco: Time to act is now
por: El Bairi, Khalid, et al.
Publicado: (2021)

Tracing ovarian cancer research in Morocco: A bibliometric analysis
por: El Bairi, Khalid, et al.
Publicado: (2021)

Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021)

An unusual presentation of ovarian carcinoma with supraclavicular lymph node and colorectal metastases leading to spontaneous rectovaginal fistula
por: Kharmach, Ikram, et al.
Publicado: (2023)

Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
por: Al Jarroudi, Ouissam, et al.
Publicado: (2020)

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
por: You, Xia-Hong, et al.
Publicado: (2019)

Métastase vésicale d'un adénocarcinome gastrique en bague à chaton
por: Seddik, Youssef, et al.
Publicado: (2014)

Overweight: Is It a Prognostic Factor in Women with Triple-Negative Breast Cancer?
por: Jarroudi, Ouissam Al, et al.
Publicado: (2017)

Unusual Metastasis From Breast Cancer: Case Report
por: Jaouani, Laila, et al.
Publicado: (2021)

Undifferentiated Sarcoma: A Rare Tumor of the Prostate
por: Jaouani, Laila, et al.
Publicado: (2023)

Serum procalcitonin as a tumor marker in lung adenocarcinoma with ovarian metastasis: a case report
por: Omari, Mouhsine, et al.
Publicado: (2023)

Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
por: Al jarroudi, Ouissam, et al.
Publicado: (2021)

Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers
por: El Bairi, Khalid, et al.
Publicado: (2018)

An Extranodal Site of Diffuse Large B-cell Lymphoma Presenting as Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer
por: Kim, Seung Tae, et al.
Publicado: (2018)

Unusual Synchronous Colonic Metastasis of Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer
por: Yoon, Sang Eun, et al.
Publicado: (2019)

Impact of sidedness of colorectal cancer on tumor immunity
por: Takasu, Chie, et al.
Publicado: (2020)

The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2019)

Nottingham Prognostic Index is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer
por: jarroudi, O Al, et al.
Publicado: (2019)

Colon Cancer Sidedness, Presentation, and Survival at Different Stages
por: Ulanja, Mark B., et al.
Publicado: (2019)

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis
por: Kamran, Sophia C., et al.
Publicado: (2018)

An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness
por: Tsai, Hsiang-Lin, et al.
Publicado: (2019)

Impact of tumor sidedness on survival and recurrence patterns in colon cancer patients
por: Lee, Jong Min, et al.
Publicado: (2019)

Sidedness determines clinical characteristics and survival outcomes in medullary adenocarcinoma of the colon
por: Blakely, Andrew M., et al.
Publicado: (2021)

The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Kim, Seung Tae, et al.
Publicado: (2017)

Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis
por: Bylsma, Lauren C., et al.
Publicado: (2019)

Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice
por: Dinu, Ioana Mihaela, et al.
Publicado: (2023)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Prognostic Impact of Tumor Status, Nodal Status and Tumor Sidedness in Metastatic Colon Cancer
por: Mukkamalla, Shiva Kumar R, et al.
Publicado: (2020)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

ALDH1A1 expression is associated with poor differentiation, ‘right-sidedness’ and poor survival in human colorectal cancer
por: van der Waals, Lizet M., et al.
Publicado: (2018)

Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival
por: Mokhtari, Zahra, et al.
Publicado: (2023)

Triple Negative Breast Cancer at the University Hospital Mohammed VI – Oujda
por: Al jarroudi, O, et al.
Publicado: (2017)

Plant cell polarity: The many facets of sidedness
por: Dong, Juan, et al.
Publicado: (2023)

The impact of primary tumor sidedness on survival in early‐onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis
por: Azar, Ibrahim, et al.
Publicado: (2021)

The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting—A Nation-Wide Retrospective Analysis (RACER)
por: Potocki, Paweł Michał, et al.
Publicado: (2023)

Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 Plus Bevacizumab
por: Otsu, Satoshi, et al.
Publicado: (2014)

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)
por: Jin, Ran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_so78h4mf758g13qeviibu4bvkp